IBD in Clinical Practice: Malnutrition Update for Healthcare Providers 2018

Gastroenterology
Curriculum:
IBD in Clinical Practice: Malnutrition Update for Healthcare Providers 2018
Credits:
1 AMA PRA Category 1 Credit(s)™
Launch Date:
29-Mar-18
Expiration Date:
29-Mar-19

Primary Audience:

Gastroenterologists and gastroenterology nurse practitioners (NPs) and physician assistants (PAs)

Relevant Terms:

IBD, malnutrition

Caroline Hwang, MD

Caroline Hwang, MD
Assistant Professor of Clinical Medicine
Medical Director, Inflammatory Bowel Disease Center
Keck/University of Southern California School of Medicine
Los Angeles, CA

Caroline Hwang, MD, is Assistant Professor of Clinical Medicine and Medical Director of the Inflammatory Bowel Disease Center at Keck/University of Southern California School of Medicine in Los Angeles.
 
Dr. Hwang earned her medical degree from David Geffen School of Medicine at the University of California in Los Angeles. She completed her residency in internal medicine at Columbia University Medical Center in New York. She went on to complete a fellowship in gastroenterology and was a clinical research fellow in the Hereditary Cancer Prevention Program at Columbia.
 
Dr. Hwang is a member of the American Medical Association, the American Gastroenterological Association, and the American Society of Gastrointestinal Endoscopy. She is on the medical advisory board of the Crohn's & Colitis Foundation. She has received a number of awards and grants in recognition and support of her work and research in inflammatory bowel disease, education, and gastroenterology.
 
Dr. Hwang has authored multiple articles in peer-reviewed publications, such as Inflammatory Bowel Disease, Gastroenterology, and Cancer. She has been invited to talk at many meetings and symposiums, as well as present posters, abstracts, and lectures across the country.

Kelly Issokson, MS, RD, CNSC

Kelly Issokson, MS, RD, CNSC
Clinical Dietitian
Cedars-Sinai Medical Center
Los Angeles, CA

Kelly Issokson, MS, RD, CNSC, is a certified nutrition support clinician and has been a registered dietitian for over 7 years at Cedars-Sinai Medical Center in Los Angeles, California.
 
Kelly graduated magna cum laude from Johnson & Wales University in Providence, Rhode Island. She earned her masters degree in Family and Consumer Sciences and Nutrition and performed her dietetic internship at California State University in Northridge, California.
 
Kelly specializes in inflammatory bowel disease (IBD), providing nutrition counseling to hospitalized patients and joining the IBD team on rounds where she educates GI fellows and residents on the specific nutritional needs of IBD patients. Kelly also counsels GI patients in her outpatient clinic, and at the IBD Nutrition & Integrative Clinic with Dr. Eric Vasiliauskas.
 
Kelly is actively involved in nutrition research at Cedars-Sinai (with the GI and Clinical Nutrition divisions), and with the Crohn's & Colitis Foundation. Kelly has spoken at both local and national Academy of Nutrition and Dietetics (AND) conferences on the topics of IBD and other digestive conditions. She is also involved with the Crohn's & Colitis Foundation as a member of the Los Angeles Chapter Medical Advisory Committee, as well as a speaker on the topic of nutrition at local patient education events.

Gil Y. Melmed, MD, MS

Gil Y. Melmed, MD, MS
Director of Clinical Inflammatory Bowel Disease (IBD) 
Cedars-Sinai Medical Center
Associate Professor of Medicine
David Geffen University of California, Los Angeles (UCLA) School of Medicine
Los Angeles, CA

Gil Y. Melmed received his medical degree from Albert Einstein College of Medicine. He completed his residency at Cedars-Sinai Medical Center and his gastroenterology fellowship at UCLA, where he also received a master's of science in clinical research. He is board certified by the American Board of Internal Medicine in gastroenterology.

Dr. Melmed is Director of Clinical Inflammatory Bowel Disease (IBD) at Cedars-Sinai Medical Center, and Associate Professor of Medicine at the David Geffen University of California, Los Angeles (UCLA) School of Medicine. His main clinical and research interests are clinical outcomes in inflammatory bowel disease (Crohn's disease and ulcerative colitis), including health-related quality of life, post-operative outcomes, vaccination and health maintenance issues in patients with IBD, and quality of care for IBD. He has authored or co-authored over 70 publications and serves as a review editor for Inflammatory Bowel Disease. He is an active member of the Crohn's & Colitis Foundation, and co-chairs the Los Angeles Medical Advisory Committee as well as the national Quality of Care Committee.

Aline Charabaty, MD (Reviewer)

Aline Charabaty, MD (Reviewer)
Associate Professor of Medicine
Director, IBD Center
Medstar Georgetown University Hospital
Washington, DC

Aline Charabaty, MD, is an associate professor of medicine and Director of the IBD Center at Georgetown University Hospital in Washington, DC.
 
Dr. Charabaty graduated with honors from McGill University in Montreal, Canada and earned her medical degree at University St. Joseph, Faculte de Medecine in Beirut, Lebanon. She completed an internship at St. Raphael's Hospital in New Haven, Connecticut and her residency and gastroenterology fellowship at Georgetown University Hospital.
 
Dr. Charabaty is actively involved in patient and professional education. She serves on multiple educational committees and is a consultant for the FDA. She is the Chair of the Mission Committee of the Greater Washington DC Metropolitan Area Chapter of the Crohn's & Colitis Foundation, and an active member of the Crohn's & Colitis Foundation's physician education committee. She is a member of the American Society for Gastrointestinal Endoscopy, the American Gastroenterology Association, and the American College of Gastroenterologists. She has received the Celiac Champion award from the National Foundation of Celiac Awareness and the Gastroenterology Award in Excellence in Teaching Residents and Fellows from Georgetown University Hospital.  
 
Dr. Charabaty has been a reviewer for several peer-reviewed journals, including Inflammatory Bowel Disease, Clinical and Translational Gastroenterology, Gastrointestinal Endoscopy, American Journal of Gastroenterology, and Digestive Disease and Sciences. Her work and editorials have been published in numerous peer-reviewed journals and she has written book chapters on women's health and inflammatory bowel disease and radiosurgery. Dr. Charabaty has lectured and presented her studies at regional and national meetings, seminars and ground rounds.
1. Summarize the clinical significance of malnutrition and related complications
2. Identify IBD patients who are at risk for malnutrition by using the Malnutrition Universal Screening Tool (MUST)
3. Describe screening, assessment, and intervention/monitoring for malnutrition in IBD patients as outlined by the Crohn's & Colitis Foundation's IBD Nutrition Care Pathway
4. Engage IBD patients who are at risk or have malnutrition in their healthcare by implementing effective shared decision making strategies

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine, the Crohn’s & Colitis Foundation, and RMEI Medical Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
 
Physician Continuing Medical Education 
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
 
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
 
  • Caroline Hwang, MD, has affiliations with UCB (Consulting Fees); Janssen, Nestlé Health Science (Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents); AbbVie, Celgene, Eli-Lilly (Contracted Research).
  • Kelly Issokson, MS, RD, CNSC, has no affiliations with commercial interests to disclose.
  • Gil Y. Melmed, MD, MS, has affiliations with AbbVie, Celgene, Janssen, Medtronic, Pfizer, Takeda, UCB (Consulting fees).
  • Aline Charabaty, MD, has affiliations with AbbVie (Consulting Fees); AbbVie, Janssen, Takeda (Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents); Janssen (Contracted Research).
Crohn’s & Colitis Foundation
  • Sudha Sarode, MSPH, has no affiliations with commercial interests to disclose.
RMEI Medical Education, LLC
  • Sherri Kramer, MD, has no affiliations with commercial interests to disclose.
  • Faith Reidenbach, CHCP, has no affiliations with commercial interests to disclose.
  • Sharon Powell, has no affiliations with commercial interests to disclose.
Postgraduate Institute for Medicine
The PIM planners and managers, Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CHCP; Judi Smelker-Mitchek, MBA, MSN, RN; and Jan Schultz, MSN, RN, CHCP, have nothing to disclose.
 
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
 
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 
 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
  
Estimated time to complete: 1.0 hour
Medium: Internet

FEE INFORMATION
There is no fee for this educational activity.

COMMERCIAL SUPPORT
This activity is jointly provided by Postgraduate Institute for Medicine, the Crohn's & Colitis Foundation, and RMEI Medical Education, LLC. This activity is supported by an independent medical educational grant from Nestlé Health Science.
 
HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and physician assistants are entitled to receive up to 1.0 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page.
Users must:
  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the activity evaluation.
Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
 
COURSE VIEWING REQUIREMENTS
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above 
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.